Cargando…

Fosfomycin: Pharmacological, Clinical and Future Perspectives

Fosfomycin is a bactericidal, low-molecular weight, broad-spectrum antibiotic, with putative activity against several bacteria, including multidrug-resistant Gram-negative bacteria, by irreversibly inhibiting an early stage in cell wall synthesis. Evidence suggests that fosfomycin has a synergistic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dijkmans, Anneke Corinne, Ortiz Zacarías, Natalia Veneranda, Burggraaf, Jacobus, Mouton, Johan Willem, Wilms, Erik Bert, van Nieuwkoop, Cees, Touw, Daniel Johannes, Stevens, Jasper, Kamerling, Ingrid Maria Catharina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745467/ https://www.ncbi.nlm.nih.gov/pubmed/29088073 http://dx.doi.org/10.3390/antibiotics6040024

Ejemplares similares

Fosfomycin as a potential therapy for the treatment of systemic infections: a population pharmacokinetic model to simulate multiple dosing regimens
por: Ortiz Zacarías, Natalia V., et al.
Publicado: (2018)

Pharmacokinetics of fosfomycin in patients with prophylactic treatment for recurrent Escherichia coli urinary tract infection
por: Kuiper, Sander G, et al.
Publicado: (2020)

The Oral Pheneticillin Absorption Test: An Accurate Method to Identify Patients with Inadequate Oral Pheneticillin Absorption
por: Dijkmans, Anneke C., et al.
Publicado: (2019)

Serum and Prostatic Tissue Concentrations of Cefazolin, Ciprofloxacin and Fosfomycin after Prophylactic Use for Transurethral Resection of the Prostate
por: Sobels, Annemieke, et al.
Publicado: (2022)

The effect of food and formulation on the population pharmacokinetics of cholesteryl ester transferase protein inhibitor DRL‐17822 in healthy male volunteers
por: Goulooze, Sebastiaan C., et al.
Publicado: (2020)

1386. Efficacy of Repeat Dosing of Oral Fosfomycin in a Dynamic Bladder Infection In Vitro Model
por: Abbott, Iain, et al.
Publicado: (2018)

Synergistic Effects from Combination of Cryptotanshinone and Fosfomycin Against Fosfomycin-Susceptible and Fosfomycin-Resistant Staphylococcus aureus
por: Ruan, Zijing, et al.
Publicado: (2020)

Prevalent levels of RSV serum neutralizing antibodies in healthy adults outside the RSV-season
por: Van Der Plas, Johan L., et al.
Publicado: (2019)

Fosfomycin and breastfeeding
Publicado: (2020)

611. Fosfomycin Resistance of Multidrug-Resistant Escherichia coli and Mechanisms of Fosfomycin Resistance
por: Seok, Hyeri, et al.
Publicado: (2019)

A two-step deconvolution-analysis-informed population pharmacodynamic modeling approach for drugs targeting pulsatile endogenous compounds
por: van Esdonk, Michiel J., et al.
Publicado: (2017)

Model informed quantification of the feed‐forward stimulation of growth hormone by growth hormone‐releasing hormone
por: van Esdonk, Michiel J., et al.
Publicado: (2020)

Fosfomycin in antimicrobial stewardship programs
por: Rubio, Elena Múñez, et al.
Publicado: (2019)

Deciphering pharmacokinetics and pharmacodynamics of fosfomycin
por: Rodríguez-Gascón, Alicia, et al.
Publicado: (2019)

New microbiological aspects of fosfomycin
por: Díez-Aguilar, María, et al.
Publicado: (2019)

The role of fosfomycin in osteoarticular infection
por: Morata, Laura, et al.
Publicado: (2019)

Effect of Fosfomycin on Cyclosporine Nephrotoxicity
por: Ortega-Trejo, Juan Antonio, et al.
Publicado: (2020)

Effect of Glycerol on Fosfomycin Activity against Escherichia coli
por: Ortiz-Padilla, Miriam, et al.
Publicado: (2022)

Levofloxacin‐Induced QTc Prolongation Depends on the Time of Drug Administration
por: Kervezee, L, et al.
Publicado: (2016)

Oral fosfomycin versus ciprofloxacin in women with E.coli febrile urinary tract infection, a double-blind placebo-controlled randomized controlled non-inferiority trial (FORECAST)
por: ten Doesschate, Thijs, et al.
Publicado: (2018)

Quantification of the endogenous growth hormone and prolactin lowering effects of a somatostatin-dopamine chimera using population PK/PD modeling
por: van Esdonk, Michiel J., et al.
Publicado: (2020)

Pharmacological evaluation of disulfiram analogs as antimicrobial agents and their application as inhibitors of fosB-mediated fosfomycin resistance
por: Lewis, Alexandria D., et al.
Publicado: (2022)

Synergistic activity of fosfomycin–meropenem and fosfomycin–colistin against carbapenem resistant Klebsiella pneumoniae: an in vitro evidence
por: Bakthavatchalam, Yamuna Devi, et al.
Publicado: (2020)

Assessing the Emergence of Resistance in vitro and Invivo: Linezolid Combined with Fosfomycin Against Fosfomycin-Sensitive and Resistant Enterococcus
por: Li, Yaowen, et al.
Publicado: (2022)

An exploratory first‐in‐man study to investigate the pharmacokinetics and safety of liposomal dexamethasone at a 2‐ and 1‐week interval in patients with metastatic castration resistant prostate cancer
por: Vrouwe, Josephina P. M., et al.
Publicado: (2021)

Fosfomycin: Uses and potentialities in veterinary medicine
por: Pérez, D.S., et al.
Publicado: (2014)

2412. Our Experience With IV Fosfomycin
por: Savaj, Pratik, et al.
Publicado: (2018)

Fosfomycin (Veterinary Medicinal Products): Summary
Publicado: (2019)

Detection of Low-Level Fosfomycin-Resistant Variants by Decreasing Glucose-6-Phosphate Concentration in Fosfomycin Susceptibility Determination
por: Martín-Gutiérrez, Guillermo, et al.
Publicado: (2020)

Fosfomycin Resistance in Escherichia coli Isolates from South Korea and in vitro Activity of Fosfomycin Alone and in Combination with Other Antibiotics
por: Seok, Hyeri, et al.
Publicado: (2020)

Fosfomycin Resistance in Escherichia coli, Pennsylvania, USA
por: Alrowais, Hind, et al.
Publicado: (2015)

Fosfomycin: the characteristics, activity, and use in critical care
por: Hashemian, Seyed Mohammad Reza, et al.
Publicado: (2019)

Oral fosfomycin for the treatment of chronic bacterial prostatitis
por: Karaiskos, Ilias, et al.
Publicado: (2019)

Fosfomycin in the pediatric setting: Evidence and potential indications
por: Baquero-Artigao, Fernando, et al.
Publicado: (2019)

1690. Oral Fosfomycin for the Treatment of Bacterial Prostatitis
por: Kamath, Meghan, et al.
Publicado: (2020)

Acute localized exanthematous pustulosis induced by fosfomycin
por: Alfuraih, Ibrahim, et al.
Publicado: (2023)

Fosfomycin resistance mechanisms in Enterobacterales: an increasing threat
por: Mattioni Marchetti, Vittoria, et al.
Publicado: (2023)

Increasing antimicrobial resistance among uropathogens: Is fosfomycin the answer?
por: Sultan, Asfia, et al.
Publicado: (2015)

Compatibility of fosfomycin with different commercial peritoneal dialysis solutions
por: Kussmann, M., et al.
Publicado: (2017)

Oral and intravenous fosfomycin in complicated urinary tract infections
por: López-Montesinos, Inmaculada, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6imh0g5rtncb1mdcmh0ukss8ai